ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

A Novel Prognostic Tool for Glioma Based on Enhancer RNA-Regulated Immune Genes

Tian, Wei; Chen, Kegong; Yan, Guangcan; Han, Xinhao; Liu, Yanlong; Zhang, Qiuju*; Liu, Meina*哈尔滨医科大学
Frontiers in Cell and Developmental Biology2022-1-20DOI: 10.3389/fcell.2021.798445
7被引7阅读
引用收藏
分享

摘要

Background: Gliomas are the most malignant tumors of the nervous system. Even though their survival outcome is closely affected by immune-related genes (IRGs) in the tumor microenvironment (TME), the corresponding regulatory mechanism remains poorly characterized.Methods: Specific enhancer RNAs (eRNAs) can be found in tumors, where they control downstream genes. The present study aimed to identify eRNA-regulated IRGs, evaluate their influence on the TME, and use them to construct a novel prognostic model for gliomas.Results: Thirteen target genes (ADCYAP1R1, BMP2, BMPR1A, CD4, DDX17, ELN, FGF13, MAPT, PDIA2, PSMB8, PTPN6, SEMA6C, and SSTR5) were identified and integrated into a comprehensive risk signature, which distinguished two risk subclasses. Discrepancies between these subclasses were compared to explore potential mechanisms attributed to eRNA-regulated genes, including immune cell infiltration, clinicopathological features, survival outcomes, and chemotherapeutic drug sensitivity. Furthermore, the risk signature was used to construct a prognostic tool that was evaluated by calibration curve, clinical utility, Harrell's concordance index (0.87; 95% CI: 0.84-0.90), and time-dependent receiver operator characteristic curves (AUCs: 0.93 and 0.89 at 3 and 5 years, respectively). The strong reliability and robustness of the established prognostic tool were validated in another independent cohort. Finally, potential subtypes were explored in patients with grade III tumors.Conclusion: Overall, eRNAs were associated with immune-related dysfunctions in the TME. Targeting of IRGs regulated by eRNAs could improve immunotherapeutic/therapeutic outcomes.

学科与关键词

关键词
enhancer RNAsuper enhancer RNAimmune-related geneprognosisglomas
相关
加载中…
  • Development and Validation of a Novel Prognostic Model for Lower-Grade Glioma Based on Enhancer RNA-Regulated Prognostic Genes
    Tian, Wei; Yan, Guangcan; Chen, Kegong; Han, Xinhao; Zhang, Wei; Sun, Lin; Zhang, Qi; Zhang, Yafeng; Li, Yan; Liu, Meina*; Zhang, Qiuju*Frontiers in Oncology, 2022, 12: 714338.被引 4
  • An integrated analysis of enhancer RNAs in glioma and a validation of their prognostic values
    Lin, Han; Yang, Yong; Hou, Chongxian; Zheng, Jiantao; Lv, Guangzhao; Mao, Rui; Xu, Peihong; Chen, Shanwei; Zhou, Yujun; Wang, Peng*; Zhou, Dong*American Journal of Translational Research, 2021, 13(8): 8611-8631.被引 8
  • Prognostic Features of the Tumor Immune Microenvironment in Glioma and Their Clinical Applications: Analysis of Multiple Cohorts
    Zhang, Chunlong; Zhang, Yuxi; Tan, Guiyuan; Mi, Wanqi; Zhong, Xiaoling; Zhang, Yu; Zhao, Ziyan; Li, Feng*; Xu, Yanjun*; Zhang, Yunpeng*Frontiers in Immunology, 2022, 13: 853074.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Cell and Developmental Biology
发表日期
2022-01-20
卷期
第 9 卷
页码
798445
DOI
10.3389/fcell.2021.798445
期刊等级
3区
成果收录
SCIE

作者

  • T

    Tian, Wei (第一作者)

    harbin med univ

  • C

    Chen, Kegong

    2 · harbin med univ

查看全部 7 位作者收起作者
  • Y

    Yan, Guangcan

    harbin med univ

  • H

    Han, Xinhao

    harbin med univ

  • L

    Liu, Yanlong

    harbin med univ

  • Z

    Zhang, Qiuju (通讯)

    harbin med univ

  • L

    Liu, Meina (通讯)

    harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417